Key result
Ropivacaine significantly reduced the time to achieve complete pain relief (5.46 vs 16.07 minutes) and prolonged analgesia duration compared to levobupivacaine in elderly orthopedic patients.
Why the study?
Postoperative pain management in elderly patients is challenging due to altered pharmacokinetics and vulnerability to drug complications, making regional anesthesia preferred.
Does ropivacaine improve postoperative epidural analgesia compared to levobupivacaine in geriatric patients undergoing orthopedic surgeries?
RCT (n=56)
Randomly allocated
No
Does ropivacaine improve postoperative epidural analgesia compared to levobupivacaine in geriatric patients undergoing orthopedic surgeries?
Absolute Event Rate: 5.46% vs 16.07%
p-value: p=<0.001
Ropivacaine provides better continuous epidural infusion characteristics than levobupivacaine in geriatric orthopedic patients due to earlier motor block recovery and prolonged analgesia.
Supports preferring ropivacaine for epidural analgesia in elderly orthopedic patients; extends RCT evidence versus levobupivacaine on onset and duration.
Background: With increasing life expectancy, improved healthcare and increasing prosperity, the proportion of elderly population is increasing throughout the world. Post-operative pain management among elderly patients is a challenging and daunting task for anaesthesiologists. Altered redistribution kinetics as well as compromised drug clearance capacity render geriatric patients particularly vulnerable to drug-induced complications. Regional anaesthesia is preferred for the older patients because this form of anaesthesia causes the least interference with the metabolic functions.Subjects and Methods:56 elderly patients scheduled for elective orthopaedic lower limb surgery under epidural anaesthesia with continuous post-operative epidural analgesia were enrolled in this prospective randomised study and were randomly allocated to two groups consisting 28 patients each as under: Group I : Epidural analgesia Ropivacaine 0.2% @ 6ml/hr. Group II: Epidural analgesia Levobupivacaine 0.2% @ 6ml/hr. Statistical evaluation: Hemodynamic profiles, Onset of analgesia, extent of sensory and motor block were recorded. To compare the change in a parameter at two different time intervals paired "t" test was used. Block characteristics were analysed using Mann Whitney U test.Results:Both Ropivacaine and levobupivacaine provided excellent analgesic effect, a good hemodynamic stability and complication free infusion. As compared to levobupivacaine, ropivacaine had an early motor block recovery, early achievement of VAS score 0, ability to achieve higher levels of block and finally prolongation of analgesic effect even after the infusion was stopped.Conclusion:As compared to levobupivacaine, ropivacaine seems to be a better option for continuous epidural infusion owing to early motor block recovery and prolonged analgesia after the infusion was stopped.
No takes yet. Share an insight, caveat, or question.
Misra et al. (2020) conducted an RCT in Postoperative pain (n=56). Ropivacaine vs. Levobupivacaine 0.2% at 6 ml/hr was evaluated on Time taken to achieve VAS score 0 (minutes) (p=<0.001). Ropivacaine significantly reduced the time to achieve complete pain relief (5.46 vs 16.07 minutes) and prolonged analgesia duration compared to levobupivacaine in elderly orthopedic patients.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: